Company profile
ProtoKinetix, Incorporated
OTC: PKTX · Healthcare · Biotechnology
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ 37GM —SS 39
v0.1 · 25/100 weight · pillars only
↑ balance-sheet leverage, listing tenure · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$48.7k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$364.2k
Employees
5
as of 2026-08-25
Market cap
$78.3k
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02014
Net income-$364.2k-$364.2k2024
Operating income-$24.9M-$24.9M2012
Total assets$466.1k$466.1k2024
Liabilities$45.0k$45.0k2020
Equity$342.1k$342.1k2024
Revenue trend
FY2011 – FY2014 · USD
FY11
FY11
FY12
FY13
FY14
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is ProtoKinetix, Incorporated’s revenue?
ProtoKinetix, Incorporated booked $0 in FY2014 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Priority Aviation, Inc.——PaxMedica, Inc. Common Stock——Digicann Ventures Inc.16DWellstar International, Inc.——Wesana Health Holdings Inc.——Pathfinder Cell Therapy, Inc.——Key facts
CEOMichael Richard Guzzetta
SectorHealthcare
IndustryBiotechnology
HeadquartersMarietta, OH
ExchangeOTC: PKTX
Employees5
IPO date2002-04-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.